Overcoming barriers to adult immunization

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• Herpes zoster (shingles) and postherpetic neuralgia (PHN) are significant health concerns.
• The herpes zoster vaccine demonstrates efficacy in reducing shingles incidence and PHN development.
• Despite proven benefits, vaccination rates among eligible adults are suboptimal.

Purpose of the Study:

• To review the effectiveness of the herpes zoster vaccine.
• To identify factors influencing patient uptake of the vaccine.
• To explore strategies for improving herpes zoster vaccination coverage.

Main Methods:

• Review of existing literature on herpes zoster vaccine efficacy and uptake.
• Analysis of survey data regarding patient vaccination behaviors.
• Examination of factors affecting vaccine acceptance, including physician influence and reimbursement.

Main Results:

• The herpes zoster vaccine significantly lowers the risk of shingles and PHN.
• Physician recommendations and standing orders are associated with increased uptake of other vaccines (influenza, pneumococcal).
• Barriers such as reimbursement issues may hinder herpes zoster vaccine adoption.

Conclusions:

• The herpes zoster vaccine is a valuable tool for preventing shingles and PHN.
• Strategies to boost vaccine uptake should include strong physician endorsement.
• Addressing practical barriers, including cost and insurance coverage, is crucial for wider vaccine accessibility.